 
          
            Tableau 1 : Caractéristiques des tumeurs primitives
          
        
        
          Délai entre le diagnostic initial et l'apparition des métastases
        
        
          Test
        
        
          <5 ans
        
        
          >=5 ans
        
        
          N=622
        
        
          N=530
        
        
          Taille
        
        
          T-test
        
        
          P = <0.001
        
        
          Médiane [Min;Max]
        
        
          30.0 [0.0;200.0]
        
        
          20.5 [1.0;210.0]
        
        
          pN
        
        
          N0
        
        
          153
        
        
          (25.1%)
        
        
          220
        
        
          (42.6%)
        
        
          N+ 1 à 3
        
        
          216
        
        
          (35.4%)
        
        
          179
        
        
          (34.6%)
        
        
          N+ > 3
        
        
          118
        
        
          (19.0%)
        
        
          70
        
        
          (13.5%)
        
        
          X
        
        
          122
        
        
          (20.0%)
        
        
          46
        
        
          (8.9%)
        
        
          Grade histologique
        
        
          Chi-2
        
        
          P = <0.001
        
        
          SBR
        
        
          I
        
        
          38
        
        
          (6.2%)
        
        
          83
        
        
          (16.1%)
        
        
          II
        
        
          284
        
        
          (46.0%)
        
        
          260
        
        
          (50.4%)
        
        
          III
        
        
          Non évaluable
        
        
          276
        
        
          19
        
        
          (44.7%)
        
        
          (3.1%)
        
        
          109
        
        
          64
        
        
          (21.1%)
        
        
          (12.4%)
        
        
          Groupe tumoral
        
        
          Chi-2
        
        
          P = <0.001
        
        
          HER2 positive
        
        
          59
        
        
          (11.1%)
        
        
          11
        
        
          (3.2%)
        
        
          Luminal A-like
        
        
          85
        
        
          (16.0%)
        
        
          100
        
        
          (29.1%)
        
        
          Luminal B-like/HER2+
        
        
          61
        
        
          (11.5%)
        
        
          35
        
        
          (10.2%)
        
        
          Luminal B-like/HER2-
        
        
          198
        
        
          (37.4%)
        
        
          160
        
        
          (46.5%)
        
        
          Triple negative
        
        
          127
        
        
          (24.0%)
        
        
          38
        
        
          (11.0%)